Cuba vs Suriname: Cause of death, by non-communicable diseases, ages 15-59, female
Cuba
56.9%
in 2021
Suriname
58.4%
in 2021
Cuba rank
107th
Suriname rank
104th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Cuba
- Suriname
How they compare
Suriname currently reports 58.4% against 56.9% in Cuba, a difference of 1.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Cuba ahead.
Cuba ranks 107th and Suriname ranks 104th of 185 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.9% | 50.5% | 29.4% | Cuba |
| 2010s | 85.4% | 67.5% | 17.9% | Cuba |
| 2020s | 72.2% | 63.8% | 8.3% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Cuba or Suriname?
- Suriname, at 58.4% against 56.9% in Cuba as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Cuba and Suriname?
- 1.5%, with Suriname ahead.
- How many years of comparable data are there for Cuba and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Cuba and Suriname rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Cuba ranks 107th and Suriname ranks 104th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.